TetraLogic Pharma Prices 7.15 Mln Shares IPO At $7/Shr - Quick Facts

TetraLogic Pharmaceuticals Corp. (TLOG) has priced its initial public offering or IPO of 7.15 million shares at $7.00 per share price, before underwriting discount and offering costs. All common shares are being offered by TetraLogic. Further, the underwriters were granted a 30-day option to buy up to an additional 1.07 million shares at the same price to cover over-allotments, if any. The shares may commence trading on the NASDAQ Global Market on December 12, 2013 under the symbol "TLOG." The offering may close on December 17, 2013.

TetraLogic plans to use the net proceeds of its IPO to advance the clinical and pre-clinical development of birinapant, other development programs, working capital and general corporate purposes. Oppenheimer & Co. Inc., Guggenheim Securities, LLC and Needham & Company, LLC are acting as joint book-running managers for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sturtevant, Wisconsin-based BRP U.S. Inc. is recalling around 20 models of Side-by-Side vehicles citing fire risk, the U.S. Consumer Product Safety Commission. The recall involves about 34,400 units of Model Years 2020 and 2021 Can-AM Defender HD10 side-by-side vehicles. While reporting financial results for the second quarter on Friday, technology company Honeywell international Inc. (HON) raised its adjusted earnings and sales guidance for the full-year 2021, based on the second-quarter performance and management's outlook for the remainder of the year. For fiscal... Shares of Vodafone Group Plc were gaining around 2 percent in the morning trading in London after the British telecom major reported higher revenues in its first quarter. Looking ahead, the company said it is on track to deliver fiscal year 2022 guidance, with Adjusted EBITDAaL expected to be between 15.0 billion euros - 15.4 billion euros and Adjusted free cash flow of at least 5.2 billion euros
Follow RTT